420 participants
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2025-02-13
- Completion:
- 2031-03-31
Conditions
- Chronic Migraine
Interventions
- DRUG
No Results Yet